• Other

    Other
  • CN

    CN
  • EU

    EU
  • USA

    USA
    • My cart
    In the shopping cart is not goods, to choose and buy!
    • Product Name
    • Size
    • Quantity
    • Amount
      Selected items : 0 pieces Total : CHECK OUT()
      PF-3716556
      PF-3716556

      Price：
      Market Price：

      This product is for research use only, not for human use. We do not sell to patients.
      Number： - + Pieces（InventoryPieces）
      InvivoChem Cat #: V1639
      CAS #: 928774-43-0Purity ≥98%

      Description: PF 3716556 (PF3716556; PF-3716556) is a novel, potent and selective P-CAB (potassium-competitive acid blocker: acid pump antagonist) with anti-acid reflux activity. It inhibits P-CAB with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively. PF-3716556 inhibits gastric acid secretion and thus has the potential for the treatment of gastroesophageal reflux disease. It displays no activity at Na+,K+-ATPase. PF-03716556 did not display any species differences, exhibiting highly selective profile including the canine kidney Na(+),K(+)-ATPase. 

      References: J Pharmacol Exp Ther. 2009 Feb;328(2):671-9.

      Customer Validation
      Top Publications Citing Invivochem Products
      • Citation of InvivoChem Vorinostat (V0255) by Nature 2021, 597(7874):119-125
      • Citation of InvivoChem Larotrectinib (V2599) by Cell. 2020 Nov 25;183(5):1202-1218.e25
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3
      • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, doi: 10.1016/j.cell.2020.10.016.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, doi: 10.1126/sciadv.abm9427.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem Vitrakvi by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem APR-246 by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem LOXO-101 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem ARRY-470 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, doi: 10.1126/sciadv.abm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem V33339 Lys-SMCC-DM1 by PNAS Nexus 2022, pgac063, https://academic.oup.com/pna
      • Citation of InvivoChem 5-azacytidine by Nature 2021, PMID: 34433969
      • Citation of InvivoChem Ruxolitinib/Filgotinib/BMS-911543/Decernotinib by J Allergy Clin Immunol 2020
      • Citation of InvivoChem LGK974 /WNT974 (V1353) by Cancer Cell 2021 Apr 12;39(4):529-547.e7.
      • Citation of InvivoChem V1386 Napabucasin (BBI-608) by J Exp Clin Cancer Res 2021 Oct 13;40(1):319.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem Epacadostat/INCB024360 (V0942) by Cancer Discov 2022: 12(4):1106-1127.
      • Citation of InvivoChem S63845 (V2797) by Cell Death and Disease 2020, 11:316.
      • Citation of InvivoChem BMS-582949 (V2668) by Cells 2020, 9(6):1472.
      • Citation of InvivoChem Apiin (V4467) by J Med Chem 2020, 63(15):8338-8358.
      • Citation of InvivoChem V0001 venetoclax by WO2021231323A1

      详情页公告Product Catalog 2022

      Bulletin Board

      详情页公告Guide to Product Handling


      Publications Citing InvivoChem Products
      • Physicochemical and Storage Information
      • Protocol
      • Quality Control Documentation
      • Related Biological Data
      • Customer Review
      Molecular Weight (MW)394.47
      FormulaC22H26N4O3
      CAS No.928774-43-0
      Storage-20℃ for 3 years in powder form
      -80℃ for 2 years in solvent
      Solubility (In vitro)DMSO: 79 mg/mL (200.3 mM)
      Water:<1 mg/mL
      Ethanol: 79 mg/mL (200.3 mM)
      Other infoChemical Name: N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide
      InChi Key: YBHKBMJREUZHOV-QGZVFWFLSA-N
      InChi Code: InChI=1S/C22H26N4O3/c1-14-5-4-6-19-20(14)17(7-10-29-19)24-18-11-16(22(28)25(3)8-9-27)13-26-12-15(2)23-21(18)26/h4-6,11-13,17,24,27H,7-10H2,1-3H3/t17-/m1/s1
      SMILES Code: O=C(C1=CN2C(C(N[[email protected]@H]3CCOC4=C3C(C)=CC=C4)=C1)=NC(C)=C2)N(CCO)C
      SynonymsPF-3716556; PF 3716556; PF3716556; PF-03716556; PF 03716556; PF03716556


      • Molarity Calculator
      • Dilution Calculator
      • The molarity calculator equation

        Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

        • Mass
        • Concentration
        • Volume
        • Molecular Weight *
        • =
        • ×
        • ×
      • The dilution calculator equation

        Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

        This equation is commonly abbreviated as: C1V1 = C2V2

        • Concentration (start)
        • ×
        • Volume (start)
        • =
        • Concentration (final)
        • ×
        • Volume (final)
        • ×
        • =
        • ×
        • C1
        •  
        • V1
        •  
        • C2
        •  
        • V2
      In Vitro

      In vitro activity: PF-03716556 is a potent, and selective acid pump antagonist with pIC50 of about of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively. PF-03716556 is used for the treatment of gastroesophageal reflux disease. PF-03716556 is highly selective for H+, K+-ATPase in vitro, displays no activity at Na+, K+-ATPase. PF-03716556 has no species differences among the porcine, canine and human enzymes. PF-03716556 has a competitive and reversible mode of action.

      Kinase Assay: PF 03716556 is a potent, and selective H+, K+-ATPase antagonist, with a pIC50 value of 6.009.

      In VivoPF-03716556 inhibits gastric acid secretion in rat and dog models. PF-03716556 offers long-lasting and maximal efficacy within 30 min of a single dosing with responses that are maintained for at least 5 days of repeated dosing with no signs of tolerance. 
      Animal modelRats
      Formulation & DosageDissolved in 5% DMSO and 15% Cremophor EL; 1–10 mg/kg; 1 ml/kg; i.v. injection
      ReferencesJ Pharmacol Exp Ther. 2009 Feb;328(2):671-9.

      These protocols are for reference only. InvivoChem does not independently validate these methods.

      评论

        Home Prev Next Last page / pices

        发评论

        ×
        Your information is safe with us. * Required Fields.
        Products are for research use only;  We do not sell to patients
        Contact Us
        Contact Us
        Tel: 1-708-310-1919
        Fax: 1-708-557-7486
        Email: [email protected]
        Frequently Asked Questions
        Subscribe to our E-newsletter
        • Name*
        • *
        • E-mail*
        • *
        • instructions：
        • *
        Copyright 2020 InvivoChem LLC | All Rights Reserved
          Site map
        prompt
        Do you confirm the receipt?